ACC 2025 | SMART-CHOICE 3 trial: Clopidogrel como monoterapia versus aspirina após ICP em pacientes de alto risco
Plataforma Med.IQ
1 min
10 abr, 2025
Carregando conteúdo…
Referências
- Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH, et al. Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. The Lancet. 2025 Mar 30. doi: 10.1016/S0140-6736(25)00449-0.
